Skip to content

Study · Not a test of the peptide alone · 2012

4 results

Role of optimizing testosterone before microdissection testicular sperm extraction in men with nonobstructive azoospermia.

Reifsnyder JE, Ramasamy R, Husseini J, Schlegel PN

The Journal of urology15 Jun 2012Cited by 93 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone4

In this study, hCG (human chorionic gonadotropin) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking hCG (human chorionic gonadotropin).

  1. 01HumanNot a test of hCG (human chorionic gonadotropin) aloneObservational studyEfficacy outcome

    In men with azoospermia, sperm retrieval was similar with pretreatment testosterone below 300 ng/dl after pooled medical therapy (52% versus 56%).

    In plain wordsIn men with azoospermia, pooled testosterone optimization therapy yielded similar sperm retrieval to men with higher baseline testosterone.

    Outcome
    No significant changeSperm retrieval by baseline testosterone
    Study

    n = 736

    Comparator
    Baseline testosterone greater than 300 ng/dl
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Measurements

    Sperm retrieval rate
    52%
    348 men with pretreatment testosterone less than 300 ng/dl, pooled medical therapy
    Sperm retrieval rate
    56%
    388 men with baseline testosterone greater than 300 ng/dl
    p value for sperm retrieval by baseline testosterone
    0.29 p value
    Pretreatment testosterone less than 300 versus baseline testosterone greater than 300 ng/dl
    Patient count in lower-testosterone group
    348 men
    Pretreatment testosterone less than 300 ng/dl, sperm retrieval comparison
    Patient count in higher-testosterone group
    388 men
    Baseline testosterone greater than 300 ng/dl, sperm retrieval comparison

    Source sentences

    Summary
    In the remaining 348 men with pretreatment testosterone levels less than 300 ng/dl, the sperm retrieval rate was similar (52%, p = 0.29).
    Summary
    Of the 736 men who had preoperative hormonal data 388 (53%) had baseline testosterone levels greater than 300 ng/dl.
    2 context sentences
    Summary · context
    The sperm retrieval rate in these men was 56%.
    Summary · context
    Patients with preoperative testosterone levels less than 300 ng/dl were treated with aromatase inhibitors, clomiphene citrate or human chorionic gonadotropin before microdissection testicular sperm extraction with the goal of optimizing testosterone levels.

    In this study, hCG (human chorionic gonadotropin) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking hCG (human chorionic gonadotropin).

  2. 02HumanNot a test of hCG (human chorionic gonadotropin) aloneObservational studyEfficacy outcome

    In men with azoospermia, sperm retrieval rates were similar in responders and nonresponders to hormonal therapy including hCG.

    In plain wordsIn men with azoospermia, sperm retrieval was similar in responders and nonresponders to hormonal therapy including hCG.

    Outcome
    No significant changeSperm retrieval by hormonal response
    Study

    n: not reported in source

    Comparator
    Nonresponders to hormonal therapy
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Source sentences

    Summary
    In addition, the sperm retrieval, clinical pregnancy and live birth rates were similar between men who responded to hormonal therapy and those who did not.
    1 context sentence
    Summary · context
    Patients with preoperative testosterone levels less than 300 ng/dl were treated with aromatase inhibitors, clomiphene citrate or human chorionic gonadotropin before microdissection testicular sperm extraction with the goal of optimizing testosterone levels.

    In this study, hCG (human chorionic gonadotropin) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking hCG (human chorionic gonadotropin).

  3. 03HumanNot a test of hCG (human chorionic gonadotropin) aloneObservational studyEfficacy outcome

    In men with azoospermia, clinical pregnancy rates were similar in responders and nonresponders to hormonal therapy including hCG.

    In plain wordsIn men with azoospermia, clinical pregnancy rates were similar in responders and nonresponders to hormonal therapy including hCG.

    Outcome
    No significant changeClinical pregnancy by hormonal response
    Study

    n: not reported in source

    Comparator
    Nonresponders to hormonal therapy
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Source sentences

    Summary
    In addition, the sperm retrieval, clinical pregnancy and live birth rates were similar between men who responded to hormonal therapy and those who did not.
    1 context sentence
    Summary · context
    Patients with preoperative testosterone levels less than 300 ng/dl were treated with aromatase inhibitors, clomiphene citrate or human chorionic gonadotropin before microdissection testicular sperm extraction with the goal of optimizing testosterone levels.

    In this study, hCG (human chorionic gonadotropin) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking hCG (human chorionic gonadotropin).

  4. 04HumanNot a test of hCG (human chorionic gonadotropin) aloneObservational studyEfficacy outcome

    In men with azoospermia, live birth rates were similar in responders and nonresponders to hormonal therapy including hCG.

    In plain wordsIn men with azoospermia, live birth rates were similar in responders and nonresponders to hormonal therapy including hCG.

    Outcome
    No significant changeLive birth by hormonal response
    Study

    n: not reported in source

    Comparator
    Nonresponders to hormonal therapy
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Source sentences

    Summary
    In addition, the sperm retrieval, clinical pregnancy and live birth rates were similar between men who responded to hormonal therapy and those who did not.
    1 context sentence
    Summary · context
    Patients with preoperative testosterone levels less than 300 ng/dl were treated with aromatase inhibitors, clomiphene citrate or human chorionic gonadotropin before microdissection testicular sperm extraction with the goal of optimizing testosterone levels.

    In this study, hCG (human chorionic gonadotropin) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking hCG (human chorionic gonadotropin).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Registered trials1

Trials this study reports on, or that list this study as a reference. Registry data from ClinicalTrials.gov.

1 trial · 1 completed · source ClinicalTrials.gov (opens in a new tab)

CompletedPhase not statedNCT05110391

Sperm Retrieval Rates in Non-obstructive Azoospermic Men Subjected to Gonadotropin Therapy

ANDROFERT - Clinica de Andrologia e Reproducao Humanan = 6161 Feb 2014 to 15 Sept 2021

Non-obstructive Azoospermia · Hormone Deficiency · Hypogonadism, Male · Male Infertility

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.